Hiroyuki Matsuno Selected Research

Hiroyuki Matsuno Research Topics

Disease

7	Thrombosis (Thrombus) 01/2006 - 01/2002
4	Vascular System Injuries 01/2006 - 11/2003
3	Fibrosis (Cirrhosis) 02/2013 - 12/2008
3	Myocardial Infarction 01/2006 - 10/2002
2	Sandhoff Disease (Sandhoff's Disease) 01/2011 - 06/2009
2	Hypercholesterolemia 08/2006 - 07/2004
2	Heart Failure 01/2006 - 10/2002
2	Pathologic Constriction (Stenosis) 01/2006 - 07/2004
2	Ganglion Cysts (Ganglion) 10/2004 - 10/2002
2	Ischemia 10/2004 - 10/2002
2	Venous Thrombosis (Deep-Vein Thrombosis) 06/2002 - 01/2002
1	Cognitive Dysfunction 01/2016
1	Bone Diseases (Bone Disease) 03/2011
1	Systemic Scleroderma (Systemic Sclerosis) 01/2010
1	Albuminuria 11/2009
1	Pulmonary Edema 01/2006
1	Atherosclerotic Plaque (Atheroma) 01/2006
1	Atherosclerosis 01/2006
1	Neointima 07/2004
1	Vascular Remodeling 07/2004
1	Vascular Diseases (Vascular Disease) 03/2004
1	Hemorrhage 07/2003
1	Pulmonary Embolism 07/2003
1	Hypothermia 10/2002
1	Sudden Death 10/2002
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2002
1	Pulmonary Heart Disease (Cor Pulmonale) 10/2002
1	Infarction (Infarctions) 10/2002
1	Carotid Artery Thrombosis 06/2002
1	Osteoporosis 01/2002

Drug/Important Bio-Agent (IBA)

4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2006 - 10/2002
4	Fibrinolysin FDA Link 01/2006 - 01/2002
3	Plasminogen Activator Inhibitor 1IBA 07/2003 - 02/2002
2	Bleomycin (Blenoxane)FDA LinkGeneric 02/2013 - 01/2010
2	G(M2) Ganglioside (Ganglioside GM2)IBA 01/2011 - 06/2009
2	OligosaccharidesIBA 01/2011 - 06/2009
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2010 - 01/2006
2	Matrix Metalloproteinases (MMPs)IBA 12/2008 - 07/2004
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2006 - 03/2004
2	PlasminogenIBA 01/2006 - 01/2002
2	Crystallins (Crystallin)IBA 01/2006 - 06/2005
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 06/2005 - 01/2002
2	Retinaldehyde (Retinal)IBA 10/2004 - 10/2002
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Phospholipases (Phospholipase)IBA 02/2013
1	CalciumIBA 02/2013
1	Lipase (Acid Lipase)FDA Link 02/2013
1	ProstaglandinsIBA 02/2013
1	Prostaglandins FIBA 02/2013
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2013
1	Calcium-Independent Phospholipases A2IBA 02/2013
1	ChemokinesIBA 01/2011
1	Dinoprostone (PGE2)FDA Link 01/2011
1	Hexosaminidases (Hexosaminidase)IBA 01/2011
1	Adenosine Diphosphate (ADP)IBA 11/2009
1	AcetylglucosamineIBA 06/2009
1	beta-N-AcetylhexosaminidasesIBA 06/2009
1	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 08/2006
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 08/2006
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2006
1	activin AIBA 01/2006
1	CollagenIBA 01/2006
1	CoagulantsIBA 01/2006
1	AnticoagulantsIBA 01/2006
1	LipidsIBA 01/2006
1	Becaplermin (PDGF-BB)FDA Link 06/2005
1	p38 Mitogen-Activated Protein KinasesIBA 06/2005
1	Platelet-Derived Growth FactorIBA 06/2005
1	platelet-derived growth factor AIBA 06/2005
1	MitogensIBA 06/2005
1	Glutamic Acid (Glutamate)FDA Link 10/2004
1	NeurotoxinsIBA 10/2004
1	Kainic Acid (Kainate)IBA 10/2004
1	N-Methylaspartate (NMDA)IBA 10/2004
1	Matrix Metalloproteinase InhibitorsIBA 07/2004
1	N- hydroxy- 5- ethoxymethyloxy- 2- methyl- 4- (4- phenoxybenzoyl)aminopentanamideIBA 07/2004
1	Proteins (Proteins, Gene)FDA Link 07/2004
1	Simvastatin (Zocor)FDA LinkGeneric 03/2004
1	(2S)- 2- (4- (((3S)- 1- acetimidoyl- 3- pyrrolidinyl)oxy)phenyl)- 3- (7- amidino- 2- naphtyl)propanoic acidIBA 07/2003
1	Heparin (Liquaemin)FDA LinkGeneric 07/2003
1	Plasminogen Activators (Plasminogen Activator)IBA 07/2003
1	Factor Xa InhibitorsIBA 07/2003
1	Factor Xa (Coagulation Factor Xa)IBA 07/2003
1	alpha-Crystallin B ChainIBA 01/2003
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 10/2002
1	monosodium(2- (6- hydroxynaphthalen- 2- yl)- 6- methylpyrimidin- 4- yloxy)acetate dihydrateIBA 06/2002
1	Thrombin FDA Link 06/2002
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2002
1	GlucocorticoidsIBA 01/2002

Therapy/Procedure

6	Therapeutics 03/2011 - 01/2002
1	Lasers (Laser) 11/2009
1	Intravitreal Injections 10/2004
1	Oral Administration 06/2002